Nevertheless, despite a less important impact in the discrimination between AD and non-AD population, T-Tau protein assay remains useful for the evaluation of diseases associated with acute brain injury (37) (e.g., encephalitis, Creutzfeldt-Jakob disease, cerebral infarction). This evidence concerns the gene MAPT and brain infarction.